159 related articles for article (PubMed ID: 35166843)
1. The structure of AcrIE4-F7 reveals a common strategy for dual CRISPR inhibition by targeting PAM recognition sites.
Hong SH; Lee G; Park C; Koo J; Kim EH; Bae E; Suh JY
Nucleic Acids Res; 2022 Feb; 50(4):2363-2376. PubMed ID: 35166843
[TBL] [Abstract][Full Text] [Related]
2. Structural and mechanistic insights into the CRISPR inhibition of AcrIF7.
Kim I; Koo J; An SY; Hong S; Ka D; Kim EH; Bae E; Suh JY
Nucleic Acids Res; 2020 Sep; 48(17):9959-9968. PubMed ID: 32810226
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for inhibition of the type I-F CRISPR-Cas surveillance complex by AcrIF4, AcrIF7 and AcrIF14.
Gabel C; Li Z; Zhang H; Chang L
Nucleic Acids Res; 2021 Jan; 49(1):584-594. PubMed ID: 33332569
[TBL] [Abstract][Full Text] [Related]
4. Insights into the dual functions of AcrIF14 during the inhibition of type I-F CRISPR-Cas surveillance complex.
Liu X; Zhang L; Xiu Y; Gao T; Huang L; Xie Y; Yang L; Wang W; Wang P; Zhang Y; Yang M; Feng Y
Nucleic Acids Res; 2021 Sep; 49(17):10178-10191. PubMed ID: 34432044
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis of dual anti-CRISPR and auto-regulatory functions of AcrIF24.
Kim GE; Lee SY; Birkholz N; Kamata K; Jeong JH; Kim YG; Fineran PC; Park HH
Nucleic Acids Res; 2022 Oct; 50(19):11344-11358. PubMed ID: 36243977
[TBL] [Abstract][Full Text] [Related]
6. A Type I-F Anti-CRISPR Protein Inhibits the CRISPR-Cas Surveillance Complex by ADP-Ribosylation.
Niu Y; Yang L; Gao T; Dong C; Zhang B; Yin P; Hopp AK; Li D; Gan R; Wang H; Liu X; Cao X; Xie Y; Meng X; Deng H; Zhang X; Ren J; Hottiger MO; Chen Z; Zhang Y; Liu X; Feng Y
Mol Cell; 2020 Nov; 80(3):512-524.e5. PubMed ID: 33049228
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic insights into the inhibition of the CRISPR-Cas surveillance complex by anti-CRISPR protein AcrIF13.
Wang H; Gao T; Zhou Y; Ren J; Guo J; Zeng J; Xiao Y; Zhang Y; Feng Y
J Biol Chem; 2022 Mar; 298(3):101636. PubMed ID: 35085557
[TBL] [Abstract][Full Text] [Related]
8. Mobile element warfare via CRISPR and anti-CRISPR in Pseudomonas aeruginosa.
León LM; Park AE; Borges AL; Zhang JY; Bondy-Denomy J
Nucleic Acids Res; 2021 Feb; 49(4):2114-2125. PubMed ID: 33544853
[TBL] [Abstract][Full Text] [Related]
9. Inhibition mechanisms of AcrF9, AcrF8, and AcrF6 against type I-F CRISPR-Cas complex revealed by cryo-EM.
Zhang K; Wang S; Li S; Zhu Y; Pintilie GD; Mou TC; Schmid MF; Huang Z; Chiu W
Proc Natl Acad Sci U S A; 2020 Mar; 117(13):7176-7182. PubMed ID: 32170016
[TBL] [Abstract][Full Text] [Related]
10. Disabling a Type I-E CRISPR-Cas Nuclease with a Bacteriophage-Encoded Anti-CRISPR Protein.
Pawluk A; Shah M; Mejdani M; Calmettes C; Moraes TF; Davidson AR; Maxwell KL
mBio; 2017 Dec; 8(6):. PubMed ID: 29233895
[TBL] [Abstract][Full Text] [Related]
11. Potent Cas9 Inhibition in Bacterial and Human Cells by AcrIIC4 and AcrIIC5 Anti-CRISPR Proteins.
Lee J; Mir A; Edraki A; Garcia B; Amrani N; Lou HE; Gainetdinov I; Pawluk A; Ibraheim R; Gao XD; Liu P; Davidson AR; Maxwell KL; Sontheimer EJ
mBio; 2018 Dec; 9(6):. PubMed ID: 30514786
[TBL] [Abstract][Full Text] [Related]
12. AcrIF5 specifically targets DNA-bound CRISPR-Cas surveillance complex for inhibition.
Xie Y; Zhang L; Gao Z; Yin P; Wang H; Li H; Chen Z; Zhang Y; Yang M; Feng Y
Nat Chem Biol; 2022 Jun; 18(6):670-677. PubMed ID: 35301482
[TBL] [Abstract][Full Text] [Related]
13. Foreign DNA acquisition by the I-F CRISPR-Cas system requires all components of the interference machinery.
Vorontsova D; Datsenko KA; Medvedeva S; Bondy-Denomy J; Savitskaya EE; Pougach K; Logacheva M; Wiedenheft B; Davidson AR; Severinov K; Semenova E
Nucleic Acids Res; 2015 Dec; 43(22):10848-60. PubMed ID: 26586803
[TBL] [Abstract][Full Text] [Related]
14. Anti-CRISPR protein AcrIF4 inhibits the type I-F CRISPR-Cas surveillance complex by blocking nuclease recruitment and DNA cleavage.
Gao Z; Zhang L; Ge Z; Wang H; Yue Y; Jiang Z; Wang X; Xu C; Zhang Y; Yang M; Feng Y
J Biol Chem; 2022 Nov; 298(11):102575. PubMed ID: 36209819
[TBL] [Abstract][Full Text] [Related]
15. Structural insights into the inactivation of the type I-F CRISPR-Cas system by anti-CRISPR proteins.
Yang L; Zhang Y; Yin P; Feng Y
RNA Biol; 2021 Nov; 18(sup2):562-573. PubMed ID: 34606423
[TBL] [Abstract][Full Text] [Related]
16. Insights into the inhibition of type I-F CRISPR-Cas system by a multifunctional anti-CRISPR protein AcrIF24.
Yang L; Zhang L; Yin P; Ding H; Xiao Y; Zeng J; Wang W; Zhou H; Wang Q; Zhang Y; Chen Z; Yang M; Feng Y
Nat Commun; 2022 Apr; 13(1):1931. PubMed ID: 35411005
[TBL] [Abstract][Full Text] [Related]
17. Structural basis of AcrIF24 as an anti-CRISPR protein and transcriptional suppressor.
Mukherjee IA; Gabel C; Noinaj N; Bondy-Denomy J; Chang L
Nat Chem Biol; 2022 Dec; 18(12):1417-1424. PubMed ID: 36163386
[TBL] [Abstract][Full Text] [Related]
18. Bacteriophages suppress CRISPR-Cas immunity using RNA-based anti-CRISPRs.
Camara-Wilpert S; Mayo-Muñoz D; Russel J; Fagerlund RD; Madsen JS; Fineran PC; Sørensen SJ; Pinilla-Redondo R
Nature; 2023 Nov; 623(7987):601-607. PubMed ID: 37853129
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of CRISPR-Cas systems by anti-CRISPR proteins in diverse bacterial species.
Pawluk A; Staals RH; Taylor C; Watson BN; Saha S; Fineran PC; Maxwell KL; Davidson AR
Nat Microbiol; 2016 Jun; 1(8):16085. PubMed ID: 27573108
[TBL] [Abstract][Full Text] [Related]
20. A jumbo phage that forms a nucleus-like structure evades CRISPR-Cas DNA targeting but is vulnerable to type III RNA-based immunity.
Malone LM; Warring SL; Jackson SA; Warnecke C; Gardner PP; Gumy LF; Fineran PC
Nat Microbiol; 2020 Jan; 5(1):48-55. PubMed ID: 31819217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
